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Background: Gender-related differences in morbidity and mortality are well de-
scribed for coronary artery bypass grafting but are not well understood for combined
valve and bypass surgery.
Methods: We reviewed retrospectively the morbidity and mortality of 1570 con-
secutive patients who underwent combined valve and bypass procedures at the
Toronto General Hospital between January 1990 and October 2000.
Results: There were 1073 men (68%) and 497 women (32%). The mean ages ( 1
SD) of women and men were 69  9 and 68  9 years, respectively (P  .02). Of
the 1570 total patients, 973 patients (62%) underwent aortic valve and coronary
bypass surgery , 481 patients (31%) had mitral valve and coronary bypass opera-
tions, and 116 (7%) patients had double or triple valve and coronary bypass
operations. Preoperative hypertension (P  .002), diabetes (P  .001), and atrial
fibrillation (P  .001) were seen more frequently in women. Body surface area was
significantly lower in women (P  .0001). At presentation, more women were in
congestive heart failure (69% vs 58%, P  .001) and in New York Heart Associ-
ation functional class III or IV (25% vs 19%, P  .001). Although there was no
difference in the number of women with three or more diseased vessels (32% vs
38%), only 35% of women received three or more grafts compared with 44% of men
(P .001). The use of left internal thoracic grafts, although uncommon in the whole
study population (36%), was less common in women than in men (26% vs 41%, P
 .001). Multivariable logistic analyses for morbidity and mortality showed female
gender to be an independent risk factor. Mitral valve replacement, age, left ventric-
ular dysfunction, New York Heart Association classes III and IV, and association of
tricuspid valve disease, diabetes, peripheral vascular disease, and preoperative renal
failure were found to be independent risk factors for mortality.
Conclusion: Female gender is an independent risk factor for combined morbidity
and mortality during and after combined valve and coronary bypass surgery. As with
isolated coronary artery bypass grafting, women undergoing combined procedures
have more premorbid conditions, are more often in heart failure, had an equal
incidence of triple vessel disease but received fewer grafts than men, and, therefore,
were more frequently incompletely revascularized.
Numerous studies have reported the morbidity and mortality resultsof mitral and/or aortic valve operations in combination withcoronary artery bypass grafting (CABG).1-7 However, the riskfactors influencing the early and late outcomes of valve surgerycombined with CABG (V/CABG) are not clearly defined. Addi-tionally, the impact of gender as an independent risk factor for
morbidity and mortality after V/CABG is unknown. Most studies examining iso-
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lated CABG indicate that morbidity and mortality is higher
for women than men.8-11 Thus, gender may be an indepen-
dent risk factor for morbidity and mortality after V/CABG
surgery. The present study is a retrospective descriptive
analysis undertaken to examine gender as a risk factor for
morbidity and mortality during and after combined
V/CABG.
Materials and Methods
All data were prospectively collected for 1570 consecutive patients
undergoing V/CABG at Toronto General Hospital between Janu-
ary 1990 and October 2000. These data are part of a computerized
data registry of all cardiac surgical patients at the Toronto General
Hospital.
Laboratory Investigations
Cardiac catheterization was performed in all patients over 40 years
old to assess ventricular function and the extent of coronary artery
disease. The left ventricular (LV) ejection fraction was estimated
by a single-plane ventriculogram and graded on a scale of 1 to 4 (1
  60%; 2  40%-60%; 3  20%-40%; and 4   20%).
Coronary artery narrowing of  50% was considered significant.
Operative Technique
Fentanyl citrate was used for induction and maintenance of anes-
thesia. Cardiopulmonary bypass (CPB) was established in all cases
with mild hypothermia (34°C). Myocardial protection was
achieved with cold potassium blood cardioplegia (8:1) and a
terminal hot shot in all cases. Distal anastomoses were constructed
first, followed by replacement or repair of valve(s). The proximal
anastomoses were performed after closure of the cardiac chambers.
The left internal thoracic artery (LITA) and saphenous veins were
used as conduits for CABG. Pharmacologic or mechanical support
was initiated during weaning from CPB according to standard
clinical practice. All patients were admitted to the intensive care
unit postoperatively, and then transferred to the ward when their
hemodynamic and respiratory functions were stable.
Preoperative Variables
Preoperative data that were collected included the following: age,
gender, associated diseases such as diabetes mellitus, dialysis-
dependent and nondependent renal failure, previous cardiac oper-
ations, New York Heart Association (NYHA) functional class,
extent and symptoms of coronary artery disease, LV ejection
fraction, and cardiac rhythm.
Perioperative and In-hospital Postoperative Variables
The type of valve prosthesis or reconstruction, type of conduit,
number and site of distal anastomoses, aortic crossclamp time, and
duration of CPB were recorded as operative variables. Low cardiac
output syndrome was diagnosed when the cardiac index was less
than 2 L · min1 · m2 and inotropic support (pharmacologic or
mechanical) was needed for longer than 20 minutes. Other post-
operative complications (death, myocardial infarction [MI], bleed-
ing, cerebrovascular accident, renal failure, sepsis, and wound
infection) that occurred during the hospital stay were recorded.
Outcomes
The primary outcome, hospital mortality, was defined as any
in-hospital death after surgery. Secondary outcome was defined as
combined morbidity and mortality.
Statistical Methods
SAS Statistical Software 6.12 was used for all statistical analyses
(SAS Institute, Inc, Cary, NC). Continuous variables are reported
as the mean SD in the tables and text. Gender comparisons were
made by t tests for continuous variables and by 2 or the Fisher
exact test for categorical variables. The independent, multivariable
predictors of outcome were determined by stepwise logistic re-
gression analysis using methods previously reported.12
Results
Preoperative clinical characteristics are presented in Table
1. There were a total of 1570 patients in the study popula-
tion, consisting of 1073 men (68%) and 497 women (32%).
The women were older than the men.
Of the total patients, 62% underwent an aortic valve and
CABG procedure, 31% a mitral valve and CABG proce-
dure, and 7% a double valve and CABG procedure. Addi-
tionally, 13% of both men and women had had previous
cardiac operations. Body surface area (BSA) was lower in
women than in men (1.7  0.2 m2 vs 1.9  0.2 m2, P 
.0001). Preoperative hypertension and diabetes mellitus
were more prevalent in women than in men. Women also
more frequently had a history of preoperative thromboem-
bolism in the form of transient ischemic attacks and strokes
than men. There was no significant difference in the prev-
alence of preoperative renal failure, peripheral vascular
disease, and chronic obstructive airway disease between
men and women.
More women had congestive heart failure. The majority
of patients of both sexes (83%) were in NYHA classes III
and IV, but there was a gender-related difference with
women tending to be more symptomatic. Unstable angina
was present in 25% of women and 19% of men. Preopera-
tive atrial fibrillation was more frequent in women. There
was no gender-related difference in the number of diseased
arteries, the proportion of patients with triple vessel disease,
or the incidence of left main coronary artery disease. Sim-
ilarly, LV ejection fraction was comparable between men
and women.
Operative Findings
The operative characteristics of patients are shown in Table
2. There were no differences in CPB or clamp time between
women and men. However, more women had urgent or
emergency operations than men. Although the number of
stenosed coronary arteries was equal between the sexes, and
the proportion of patients with triple vessel disease was the
same, women received fewer grafts than men. The use of
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LITA grafts, although uncommon in the whole study pop-
ulation, was less common in women than in men.
Aortic stenosis, aortic regurgitation, and mixed valvular
disease were equally frequent in men and women. Bicuspid
aortic valve disease was more common in men. Mechanical
aortic valves were used in 23% of men and 17% of women.
Biologic aortic valves were used in 75% of men and 79% of
women. Aortic valve repair (reimplantation and remodel-
ing) operations were performed in 33 patients.13,14
Mitral stenosis and mixed valve disease as well as rheu-
matic valve disease were significantly more common in
women than in men. Myxomatous mitral disease was more
common in men. Mitral valve repair was performed in 44%
of men and 18% of women. Mitral valve replacement was
more common in women. Biologic mitral valves were
used in 40% of women and 28% of men. Mechanical
mitral valves were used in the same proportion of men
and women.
TABLE 1. Preoperative clinical parameters of patients undergoing combined valve and coronary artery bypass grafting
between January 1990 and October 2000 at the Toronto General Hospital
Parameter Female Male Total P value
Patients 497 (32%) 1073 (68%) 1570 (100%)
Age (years  SD) 69 9 68 9 .02
BSA (m2) 1.68 0.20 1.93 0.20 .0001
Hypertension 278 (56%) 509 (48%) 787 (50%) .002
Diabetes 129 (26%) 188 (18%) 317 (20%) .001
PVD 71 (14%) 140 (13%) 211 (13%) NS
Renal failure 13 (2.62%) 37 (3.5%) 50 (3.18%) NS
TIA/stroke 85 (17%) 124 (12%) 209 (13%) .003
COPD 22 (4.43%) 49 (4.6%) 71 (4.52%) NS
AF 109 (22%) 136 (13%) 245 (16%) .002
CHF 341 (69%) 624 (58%) 965 (62%) .001
NYHA I 7 (1.4%) 17 (1.59%) 24 (1.5%) NS
NYHA II 47 (9.5%) 183 (17%) 230 (15%) .001
NYHA III 231 (46%) 498 (46%) 729 (46%) NS
NYHA IV 212 (43%) 374 (35%) 586 (37%) .001
Angina .001
None 145 (29%) 247 (23%) 392 (25%)
Stable 225 (45%) 518 (48%) 743 (47%)
Unstable 127 (25%) 291 (19%) 433 (19%) .001
MI 39 (7.9%) 73 (7.8%) 112 (7.1%) NS
Coronary artery disease NS
 3 299 (67.9%) 652 (62.3%) 867 (63.5%)
 3 158 (32%) 411 (38%) 569 (36%)
LMS 53 (11%) 145 (14%) 198 (13%) NS
Prior operation 70 (14%) 137 (13%) 207 (13%) NS
AV disease .001
Stenosis 194 (73%) 466 (67%) 660 (69%)
Regurgitation 119 (12%) 88 (13%) 119 (12%)
Mixed 182 (19%) 137 (20%) 182 (19%)
AV pathology .001
Rheumatic 15 (6%) 20 (3%) 35 (4%)
Tricusp/calc 160 (62%) 389 (60%) 549 (61%)
Bicuspid 47 (18%) 175 (27%) 222 (25%)
Other 53 (14%) 114 (10%) 167 (10%)
MV disease .001
Stenosis 41 (8.3%) 22 (2.05%) 63 (4.03%)
Regurgitation 134 (27%) 306 (29%) 440 (28%)
Mixed 40 (8.1%) 32 (3%) 72 (4.6%)
MV pathology .001
Rheumatic 102 (21%) 73 (6.9%) 175 (11%)
Ischemic 68 (14%) 126 (12%) 194 (13%)
Myxomatous 27 (5.5%) 117 (11%) 144 (9.3%)
AF, Atrial fibrillation; AV, aortic valve; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; LMS, left main stem; m, meter; MI,
myocardial infarction; MV, mitral valve; NS, not significant; NYHA, New York Heart Association Functional Class; PVD, peripheral vascular disease; SD,
standard deviation; TIA, transient ischemic attack.
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Outcome
Postoperative complications are shown in Table 3. Low
cardiac output syndrome, the use of intra-aortic balloon
pumping, incidence of leg infection, and requirement for
permanent pacing were higher in women than men. There
was no difference between the sexes in perioperative MI,
postoperative stroke, renal failure, sepsis, or wound infec-
tion.
Overall hospital mortality was 7% in women and 4% in
men (P  .02). Analysis in different subgroups showed that
mortality was highest in double and triple valves and CABG
(9.8%), followed by mitral valve and CABG (7.3%), and
lowest in aortic valve and CABG (3.4%). When mitral valve
repairs were excluded, overall hospital mortality was high-
est in the mitral valve replacement and CABG group
(10.62%, P  .001).
Over the 10-year period covered by this study, annual
hospital mortality for all patients decreased from 6.8% in
1990 to 1.3% in 2000. There was a trend of decreasing
mortality in men (6.9% to 0.9%). In women, in-hospital
mortality was higher than in men and did not decrease
significantly over the 10 years. Combined morbidity and
mortality decreased significantly over the 10-year period in
men but not in women (32% vs 21%, P  .002; 55% vs
38%, P  .21).
Multivariable logistic analyses for morbidity and mortal-
ity are shown in Table 4. The following risk factors were
found to be independent risks of mortality: mitral valve
replacement, age, LV dysfunction, NYHA classes III and
IV, association of tricuspid valve disease, diabetes, periph-
eral vascular disease, and preoperative renal failure. Female
gender was an independent risk factor for combined mor-
tality and morbidity even when corrected for BSA.
Discussion
More men than women (2:1) underwent combined V/CABG
procedures. The difference in rates of procedures is similar
to that seen for CABG. This difference may reflect a dif-
ference in the incidence of disease and/or a lower rate of
referral of women for the procedures. If the latter, fewer
women may be referred because of a perceived high risk
and poor outcome. Many studies, including those from our
own institution, indicate that V/CABG operations are asso-
ciated with a greater risk for early death than valve or
CABG procedures alone.13-15 Table 5 gives the gender-
specific mortality for isolated aortic, mitral, double valve,
and CABG operations at our institution during the study
period. Furthermore, our study demonstrates that operative
mortality and morbidity after V/CABG is significantly
higher in women than in men. In isolated CABG, these
differences have been attributed by other investigators to
differences in the demographic profile of women at the time
of operation16-18 or to a referral bias.18-20 Women undergo-
ing isolated CABG have more comorbid factors, such as
diabetes and hypertension, and a smaller body size than
men.20-22 In our study, this is also true for women under-
going V/CABG procedures. We found that women were
older, smaller, and had more comorbid conditions such as
hypertension, diabetes, transient ischemia attacks, and
stroke. Similarly, more women than men required urgent or
emergency operations with advanced NYHA functional
class and congestive heart failure. These latter data suggest
that the increase in morbidity and mortality may be related
to late presentation, late referral, or both.
We did not see a difference in the number of diseased
vessels, proportion of triple vessel disease, and left main
TABLE 2. Operative variables of patients undergoing combined valve and coronary artery bypass grafting between January
1990 and October 2000 at the Toronto General Hospital
Variable Female Male Total P value
Patients 497 (32%) 1073 (68%) 1570 (100%)
Priority of operation .013
Elective 278 (56%) 680 (63%) 958 (61%)
Urgent 219 (45%) 393 (36%) 612 (39%)
CPB (x min  SD) 129 3 129 39 NS
Crossclamp time (x min  SD) 98 29 100 30 NS
Distal grafts .001
 3 324 (65%) 591 (56%) 915 (58%)
 3 655 (35%) 482 (44%) 655 (42%)
LITA grafts 129 (26%) 436 (41%) 565 (36%) .001
AV surgery NS
AV repair 17 (6%) 16 (2%) 33 (3%)
AV replacement 258 (94%) 681 (98%) 939 (97%)
MV surgery .001
MV repair 32 (18%) 129 (44%) 161 (34%)
MV replacement 150 (82%) 167 (56%) 317 (66%)
AV, Aortic valve; CPB, cardiopulmonary bypass; LITA, left internal thoracic artery; MV, mitral valve; ns, not significant; SD, standard deviation; X , mean.
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stem disease between women and men. Even though there
were no differences in the number of diseased vessels
between men and women, there were significant differences
in the extent and type of revascularization. Only 35% of
women had three or more grafts versus 44% of men. This
may be incomplete revascularization for women or over-
revascularization for men. The increased incidence of low
cardiac output syndrome, use of postoperative IABP, and
increased hospital mortality suggest it is incomplete revas-
cularization for women.
Use of the LITA in men and women for V/CABG
procedures was low for both men and women but more so
for women. Other investigators have reported that use of the
LITA graft in CABG does not increase morbidity and
mortality and in some situations is associated with de-
creased mortality both in isolated CABG and in combined
V/CABG procedures.6,23,24 The lower frequency of use of
the LITA graft in our study may have contributed to the
increased mortality in women and may reflect an institu-
tional bias. Since we intended this study to be a prognostic
tool for patients undergoing combined V/CABG, all process
of care variables including LITA use were not included in
the survival statistical model.
Mitral valve replacement appears to be an independent
risk factor for morbidity and mortality in V/CABG opera-
tions. Other investigators have reported that mortality in
combined mitral valve and CABG surgery is higher for
women than men.25 In our study, women underwent mitral
valve replacements more often than men. This is most likely
related to the etiology of the valve disease. In our study,
severe mitral stenosis and mixed valve disease as well as
rheumatic valve disease were significantly more common in
women than men. Myxomatous mitral disease was more
common in men. It is known that rheumatic mitral stenosis
is less amenable to repair than myxomatous mitral regurgi-
tation and that operative mortality is lower after mitral valve
repair than after replacement.26 These findings may explain
why a significantly smaller number of women underwent
mitral valve repair as well as some of the differences in
mortality.
In our study, female gender was an independent predictor
for increased combined morbidity and mortality. Aranki and
TABLE 3. Postoperative complications of patients undergoing combined valve and coronary artery bypass grafting
between January 1990 and October 2000 at the Toronto General Hospital
Complication Female Male Total P value
MI 13 (2.6%) 19 (1.78%) 32 (2.0%) NS
LCOS 84 (17%) 110 (10%) 194 (12%) .001
IABP 45 (9.1%) 56 (5.2%) 101 (6.4%) .011
Stroke 16 (3.2%) 35 (3.2%) 51 (3.2%) NS
Renal function 10 (2.0%) 21 (2.0%) 31 (2.0%) NS
Infection leg 17 (3.4%) 18 (1.7%) 35 (2.2%) .030
Permanent pacing 45 (9.1%) 67 (6.3%) 112 (7.1%) .045
Hospital mortality 18 (7%) 45 (4%) 79 (5%) .026
Combined morbidity and mortality 192 (39%) 314 (29%) 506 (32%) .001
IABP, Intra-aortic balloon pump; LCOS, low cardiac output syndrome; MI, myocardial infarction; NS, not significant.
TABLE 4. Multivariable analysis for mortality and morbid-
ity of patients undergoing combined valve and coronary
artery bypass grafting between January 1990 and October
2000 at the Toronto General Hospital
Variable
Upper
confidence
limit Odds ratio
Lower
confidence
limit
Mitral valve replacement 3.397 2.530 1.884
Age 1.037 1.023 1.009
Female gender 1.819 1.423 1.113
Left ventricular dysfunction 1.689 1.293 0.989
NYHA class 1.769 1.378 1.073
Urgent operation 2.581 1.773 1.218
Number of diseased
vessels
1.285 1.142 1.015
Reoperation 4.660 3.032 1.973
Aortic stenosis 1.805 1.374 1.046
Endocarditis 8.444 3.025 1.084
Hypertension 1.574 1.249 0.990
PVD 1.870 1.353 0.979
Renal failure 5.242 2.739 1.431
NYHA, New York Heart Association; PVD, peripheral vascular disease.
TABLE 5. Gender-specific mortality for isolated aortic
valve replacement, mitral valve replacement double valve
replacement, and coronary artery bypass grafting between
January 1990 and October 2000 at the Toronto General
Hospital
Procedure Female (%) Male (%)
AVR 2.3 1.7
MVR 3.3 2.2
DTV 8.8 4.6
CABG 3.6 1.6
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting;
DTV, double, triple valve replacement; MVR, mitral valve replacement.
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coworkers27 also reported that female gender was a signif-
icant predictor of operative mortality in the concomitant
aortic valve replacement/CABG group but not in the iso-
lated aortic valve replacement group. In previous reports
from our unit and others,28,29 gender was not found to be an
independent risk factor in isolated valve replacement. Un-
published data from our unit suggests that female gender is
an independent predictor for isolated CABG. These data
suggest that the differences in morbidity and mortality in
women and men in V/CABG operation may be related to the
coronary artery disease and its associated comorbid conditions.
Conclusions
It is apparent that there are differences in morbidity and
mortality after combined V/CABG procedures for men and
women.
We found that female gender is an independent risk
factor for increased morbidity and mortality. It is not clear
whether the differences are due to sex-related differences in
the biology of the disease or in gender-related issues of
treatment and access to care. Further investigation is mer-
ited. In addition, perhaps it is time to acknowledge and
embrace the concept that there are differences between the
genders and to develop a separate and distinct analysis of
mortality and morbidity risks in women. Until this occurs,
careful consideration should be given to the true risks and
benefits of V/CABG for women.
We are grateful to May Farquhar for her administrative assis-
tance and we thank the cardiac surgeons of the Division of Car-
diovascular Surgery, Toronto General Hospital, University Health
Network for allowing us to review and report their results.
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